Pharmacogenetics of treatment in first-episode schizophrenia: D3 and 5-HT2C receptor polymorphisms separately associate with positive and negative symptom response

Autoria(s): Reynolds, Gavin; Yao, Z.J.; Zhang, X.B.; Sun, J.; Zhang, Z.J.
Data(s)

01/03/2005
Identificador

http://pure.qub.ac.uk/portal/en/publications/pharmacogenetics-of-treatment-in-firstepisode-schizophrenia-d3-and-5ht2c-receptor-polymorphisms-separately-associate-with-positive-and-negative-symptom-response(af2d22c3-bdf7-4dbc-bbd0-71620d1e992f).html

http://www.scopus.com/inward/record.url?scp=13244262700&partnerID=8YFLogxK
Idioma(s)

eng
Direitos

info:eu-repo/semantics/restrictedAccess
Fonte

Reynolds , G , Yao , Z J , Zhang , X B , Sun , J & Zhang , Z J 2005 , ' Pharmacogenetics of treatment in first-episode schizophrenia: D3 and 5-HT2C receptor polymorphisms separately associate with positive and negative symptom response ' European Neuropsychopharmacology , vol 15 , no. 2 , pp. 143-151 .
Palavras-Chave #/dk/atira/pure/subjectarea/asjc/2700/2728 #Clinical Neurology #/dk/atira/pure/subjectarea/asjc/2700/2738 #Psychiatry and Mental health #/dk/atira/pure/subjectarea/asjc/2800/2803 #Biological Psychiatry #/dk/atira/pure/subjectarea/asjc/2800/2808 #Neurology #/dk/atira/pure/subjectarea/asjc/3000/3004 #Pharmacology #/dk/atira/pure/subjectarea/asjc/3200 #Psychology(all)
Tipo

article
Acesso ao item digital